Tuesday, September 30, 2014 11:46:24 PM
I always appreciate your posts. I would like to better understand your passion regarding Direct. It is very evident in some of your previous posts:
"Humanity awaits the phase II multiple injection DCVAX-Direct trial that begins this fall. It will not stumble, fail or falter. This labor of love born from suffering will prevail. I do not offer my humble opinion. I give you my absolute belief."
and
"Patience. The next DCVax-Direct update will be the most impressive thus far. After that, by February or early March 2015, NWBIO and MD Anderson physicians/scientists/investigators will almost certainly present initial final trial results. I'll fly to that presentation -- neither rain, sleet or snow will keep me from my appointed duty. By that time, the multiple injection trial will also have 4-6 months under its belt. NWBO management will have to take beta-blockers to hide their excitement by that time. IMHO."
There have been several posts recently, by well respected folks on this board, encouraging caution and tempering of expectations regarding the Direct trial. You seem very adamantly opposed to any of these differing opinions. Your unwavering opinion about Direct is quite curious, especially considering the very preliminary (and limited) results that have been released thus far. Also, I am very curious about the bolded comments below made by Pyrr. Can you shed any light to help me better understand your perspective? Thanks
Pyrr - "I know you have a personal connection to seeing Direct get to patient's in need quickly, but it must be tested thoroughly first, and prove itself better than other up and coming treatments."
Recent NWBO News
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM